How to Get Finasteride in Nebraska

What finasteride is and why Nebraska residents use it

Finasteride is an FDA-approved 5-alpha-reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT). At 1 mg daily it treats androgenetic alopecia (male pattern hair loss) in men; at 5 mg daily it reduces prostate volume in benign prostatic hyperplasia (BPH). [1][2] The drug is generic, widely manufactured, and available at virtually every licensed pharmacy in Nebraska.

DHT binds androgen receptors in hair follicles and the prostate with roughly five times the affinity of testosterone. [3] Blocking its synthesis with finasteride produces measurable clinical effects within months. In a key two-year Phase III study by Kaufman et al. (N=1,553), 83% of men taking finasteride 1 mg maintained or increased hair count versus 28% on placebo, and 66% showed visible improvement by investigator global assessment. [4] A separate placebo-controlled trial published in the New England Journal of Medicine confirmed statistically significant increases in hair count at the vertex and frontal scalp (P<0.001 vs. placebo at 12 months). [5]

For BPH, finasteride 5 mg reduces prostate volume by approximately 20 to 30% over 6 to 12 months and lowers the relative risk of acute urinary retention by 57% compared with placebo in the PLESS trial (N=3,040). [6] Nebraska urologists and primary care physicians use it routinely for men with prostate volumes above 30 mL.

Nebraska prescribing authority: who can write the prescription

Any licensed MD, DO, NP, or PA holding an active Nebraska Department of Health and Human Services (DHHS) prescribing credential may write a finasteride prescription. Nebraska adopted full practice authority for nurse practitioners in 2016, so an NP does not need physician supervision to prescribe. [7] Physician assistants in Nebraska must maintain a collaborative agreement, though that agreement does not require co-signature on each prescription. [8]

The Nebraska Uniform Credentialing Act governs all prescribers. A provider must hold an active Drug Enforcement Administration (DEA) registration for controlled substances, but finasteride is not a controlled substance, so DEA registration is not required specifically for finasteride. [9] Any licensed prescriber with an active Nebraska credential and a valid patient-provider relationship may write it.

Telehealth providers operating across state lines must hold a Nebraska telehealth license or qualify under the Interstate Medical Licensure Compact (IMLC). Nebraska joined the IMLC in 2017. [10] A prescriber practicing via telemedicine from another state without Nebraska licensure cannot legally prescribe to Nebraska patients.

How telehealth prescribing works in Nebraska for finasteride

Nebraska law permits telehealth prescribing of non-controlled medications, including finasteride, without a prior in-person visit, provided the provider conducts a synchronous audio-visual encounter or completes a validated asynchronous intake process that meets the standard of care. [11] This means a Nebraska resident can complete a video or asynchronous questionnaire visit from home and receive a finasteride prescription sent electronically to a Nebraska-licensed pharmacy the same day.

The standard workflow for a telehealth finasteride visit runs as follows. First, the patient completes a medical history intake covering current medications, sexual side-effect history, prior PSA results, and any family history of prostate cancer. Second, the provider reviews the intake and, for men over 40 or those with risk factors, may order a PSA blood draw before or concurrently with prescribing. Third, the provider issues an electronic prescription to the patient's preferred pharmacy or to the telehealth platform's affiliated mail-order pharmacy. Fourth, the patient fills the prescription and begins once-daily dosing.

The Endocrine Society's 2019 clinical practice guideline on androgen therapy states that "assessment of PSA concentration is recommended before initiating androgen-deprivation agents in men over 40 years of age." [12] Most Nebraska telehealth platforms apply this guidance for finasteride as well, given finasteride's effect on PSA values. Finasteride lowers PSA by approximately 50% after 6 months of use; clinicians should double any on-treatment PSA reading to estimate the true baseline when monitoring for prostate cancer. [13]

Lab work required before starting finasteride in Nebraska

Most providers do not require labs before prescribing finasteride 1 mg for androgenetic alopecia in men under 40 with no prostate symptoms. Providers typically order baseline labs for men aged 40 and older or those with lower urinary tract symptoms.

Standard pre-treatment labs for finasteride in Nebraska include:

• PSA (prostate-specific antigen): Baseline value before finasteride artificially suppresses it. The American Urological Association (AUA) 2021 guideline on early detection of prostate cancer recommends shared-decision-making PSA screening starting at age 40 to 54 in men with risk factors. [14]
• Complete metabolic panel (CMP): Ordered when BPH is the indication to rule out renal insufficiency contributing to urinary symptoms.
• Testosterone (total): Not routinely required for finasteride alone, but ordered when concurrent TRT evaluation is planned.
• LH/FSH: Ordered only if hypogonadism is part of the differential, not standard for AGA-only prescriptions.

Nebraska has multiple LabCorp and Quest Diagnostics draw sites across Omaha, Lincoln, Bellevue, Grand Island, and Kearney, and most telehealth platforms can send lab orders to any of these locations electronically. Results return within 24 to 72 hours for PSA and CMP. [15]

The HealthRX Nebraska Finasteride Prescribing Framework assigns patients to one of three pathways based on age and indication:

• Pathway A (AGA, age <40, no urinary symptoms): Prescribe without labs at first visit; recheck PSA at 12 months.
• Pathway B (AGA or BPH, age 40 to 54): Order PSA before prescribing; recheck at 3 to 6 months on therapy.
• Pathway C (BPH, age 55+, or any elevated PSA history): Order PSA plus CMP; urology co-management recommended before or concurrent with prescribing.

How to fill a finasteride prescription at a Nebraska pharmacy

Nebraska has licensed retail pharmacies in every county. Finasteride 1 mg generic tablets are stocked at major chains including Walgreens, CVS, HyVee Pharmacy, Hy-Vee Drugstore, and Walmart Pharmacy, as well as independent pharmacies across Omaha, Lincoln, and rural communities. [16]

The FDA-approved generic finasteride 1 mg tablet is manufactured by several companies including Teva, Accord, Aurobindo, and Amneal. Any of these generics is therapeutically equivalent to brand-name Propecia per the FDA Orange Book. [1] The brand Proscar (finasteride 5 mg) and its generics are listed separately for BPH.

Retail cash prices for generic finasteride 1 mg range from approximately $15 to $40 per 30-tablet supply in Nebraska when using GoodRx or a manufacturer savings program. Finasteride 5 mg generic runs approximately $10 to $35 per 30-tablet supply. Nebraska Medicaid (Heritage Health) does not cover finasteride for androgenetic alopecia or BPH as of the current formulary. [17] Some private insurance plans in Nebraska cover finasteride 5 mg for BPH under Tier 1 or Tier 2; coverage for 1 mg AGA is inconsistently covered and often requires a step-therapy prior authorization.

Mail-order pharmacies licensed to ship to Nebraska include all major PBM-affiliated mail pharmacies (Express Scripts, OptumRx, CVS Caremark) as well as telehealth-affiliated pharmacies. A 90-day supply via mail order typically costs 20 to 30% less than three 30-day retail fills.

503A compounding pharmacies and finasteride in Nebraska

A 503A pharmacy is a traditional compounding pharmacy operating under state board of pharmacy oversight and Section 503A of the Federal Food, Drug, and Cosmetic Act. Nebraska-licensed 503A pharmacies may compound finasteride into alternative dose forms (such as topical solutions or customized capsule strengths) when a licensed prescriber writes a prescription for a specific patient and includes a clinical rationale for the deviation from commercially available products. [18]

Topical finasteride (commonly 0.1% to 0.25% solution applied to the scalp) has been evaluated in small trials. A 2018 randomized study published in the Journal of the European Academy of Dermatology and Venereology (N=52) showed topical finasteride 0.25% produced equivalent hair-count increases to oral 1 mg at 24 weeks with significantly lower serum DHT suppression, suggesting a potentially more localized effect. [19] Nebraska-licensed 503A pharmacies can prepare topical finasteride upon receipt of a valid patient-specific prescription. The compound must be prepared according to USP standards and cannot be produced in advance for office stock.

503A pharmacies differ from 503B outsourcing facilities, which produce larger batch quantities under FDA oversight. As of 2025, finasteride is not on the FDA's 503B bulk drug substance list, so Nebraska residents receiving compounded finasteride will receive it from a 503A facility. [18]

Transferring an existing finasteride prescription to Nebraska

Patients moving to Nebraska or switching pharmacies can transfer a finasteride prescription by the following steps. Transferring is straightforward because finasteride is a non-controlled medication.

Nebraska pharmacy law (Nebraska Revised Statute 38-2870) permits transfer of non-controlled prescriptions between licensed pharmacies. [20] The receiving Nebraska pharmacy contacts the previous pharmacy directly to obtain the original prescription information, remaining refills, and prescriber details. The patient does not need to revisit their prescriber for a transfer unless the original prescription has no remaining refills.

If the original prescription was issued by an out-of-state provider who is not licensed in Nebraska, the transferred prescription remains valid for its remaining refills. However, the next new prescription must come from a Nebraska-licensed prescriber or a telehealth provider with Nebraska prescribing authority. A telehealth provider can issue a new Nebraska-valid prescription within one business day in most cases.

For patients transferring from a mail-order pharmacy to a Nebraska retail pharmacy, the process is the same. Call the Nebraska pharmacy, provide the name of the previous pharmacy and prescription number, and the pharmacist handles the rest. Most transfers complete within 4 to 24 hours.

Prior authorization for finasteride in Nebraska

Prior authorization (PA) is most likely to be required when a Nebraska private insurer covers finasteride 5 mg for BPH under a step-therapy protocol, or when an employer plan includes AGA medication coverage with restrictions. Nebraska Medicaid does not cover finasteride for these indications, so PA is not relevant for Medicaid patients.

For private insurance PA, the prescriber typically submits documentation showing:

• Confirmed diagnosis (AGA via clinical exam or BPH via AUA Symptom Score and prostate measurement)
• Duration of symptoms (generally 6 or more months required)
• Failure or contraindication to a first-line alternative (for BPH, this may mean a prior trial of an alpha-blocker such as tamsulosin)
• PSA result if the insurer requires it

The American Urological Association's 2021 BPH clinical guideline supports finasteride as first-line therapy for men with prostate volumes above 30 mL, and this guideline citation often satisfies the medical necessity criterion in PA documentation. [21] Most Nebraska PA decisions for finasteride are returned within 72 hours under Nebraska Insurance Code requirements. [22]

If PA is denied, the prescriber may file a peer-to-peer review request with the insurer's medical director within the appeals window, which is typically 30 days. Generic finasteride's low cash price means many patients forgo the PA process entirely and pay out of pocket.

What to expect after starting finasteride in Nebraska

Hair regrowth from finasteride 1 mg is gradual. Most men notice reduced shedding within 3 months. Visible regrowth at the vertex typically becomes apparent between months 4 and 6, with maximum benefit at 12 to 24 months of continuous use. [4] Discontinuing finasteride results in reversal of benefit within 6 to 12 months as DHT levels return to baseline. [5]

The most discussed adverse effects are sexual side effects, including reduced libido, erectile dysfunction, and decreased ejaculate volume. In the original Merck Phase III trials, these occurred in approximately 3.8% of finasteride-treated men versus 2.1% of placebo-treated men. [5] A 2012 study in the Journal of Sexual Medicine reported that post-finasteride sexual symptoms persisted in a subset of men after discontinuation, though the incidence and causality remain debated in the literature. [23]

Finasteride lowers PSA by a mean of 50% after 12 months. [13] A Nebraska urologist or primary care physician monitoring PSA should double the measured value to interpret it relative to pre-treatment baseline. The FDA label for finasteride 5 mg (Proscar) includes this adjustment explicitly; the same principle applies to 1 mg use. [1]

For BPH, symptom improvement on the AUA Symptom Score typically begins within 3 to 6 months and continues for up to 4 years in long-term extension data from PLESS. [6] Prostate volume reduction of 20 to 30% is expected by 12 months. Men with prostate volumes below 30 mL are less likely to benefit symptomatically and may respond better to an alpha-blocker alone per AUA 2021 guidance. [21]

Nebraska prescribers generally schedule a follow-up at 3 months (to check PSA, assess tolerability, and confirm adherence) and again at 12 months for long-term monitoring. Telehealth platforms typically conduct these follow-ups via asynchronous message or a brief synchronous video check-in, which is permitted under Nebraska telehealth rules. [11]

Cost and insurance considerations for Nebraska patients

Generic finasteride 1 mg costs approximately $15 to $40 per month at Nebraska retail pharmacies without insurance. At 90-day mail-order pricing, costs can drop to $30 to $90 per quarter. GoodRx coupons are accepted at all major Nebraska pharmacy chains and at many independent pharmacies. [16]

Finasteride 5 mg generic for BPH often costs less per tablet than 1 mg despite the higher dose, due to manufacturing volume. Some men prescribed 1 mg use a pill splitter on 5 mg tablets; this practice is common but should be confirmed with the prescribing provider since tablet coating may affect splitting. The FDA has not formally approved pill-splitting for finasteride, and 5 mg tablets are not scored for halving. [1]

Nebraska's state employee health insurance plan (administered through Blue Cross Blue Shield of Nebraska) covers finasteride 5 mg for BPH on its standard formulary as a Tier 1 generic. Coverage for 1 mg for AGA varies by individual plan. Nebraska ACA marketplace plans are not required to cover finasteride under any essential health benefit category. [17]

Men enrolled in the Veterans Affairs Nebraska-Western Iowa Health Care System may receive finasteride through the VA formulary; both 1 mg and 5 mg strengths are listed on the VA National Formulary. [24]